Triple Hair Expands Global Phase III Program for TH07 with Launch of 500-Patient Trial in India

Phase III trial in India expected to enroll 500 male patients with androgenic alopecia Study forms part of Triple Hair’s coordinated international Phase III program for TH07 Harmonized clinical design supports development of a robust global data package and enhances strategic relevance across major commercial markets MONTRÉAL — Triple Hair Group Inc. (“Triple Hair” or... The post Triple Hair Expands Global Phase III Program for TH07 with Launch of 500-Patient Trial in India appeared first on Montreal Gazette .

Original source: Montreal Gazette